drugset / Trial / NCT01979965

Effect of Ranolazine on Valvular Disease in Patients With Pacemakers

NCT01979965

Phase 4 Unknown 50 enrolled University Cardiology
RandomizedParallel-groupDouble-blindSupportive care

Summary

The purpose of this study is to find out whether mitral regurgitation (or a leaky heart valve) caused by ischemic heart disease (decreased blood flow to heart muscle) will improve after administration of ranolazine.

Timeline

Start
2013-11
Primary completion
2014-05
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranolazine Small molecule